Lack of vision critical: FASTS report
24 September, 2002 by Graeme O'NeillAustralia's peak council for science and technology delivered a state-of-the-nation report to Federal Parliament this week that shows Australia slipping further off the pace among industrialised nations in its performance in science, technology and higher education.
Feds to fine-tune science blueprint
24 September, 2002 by Graeme O'NeillOnly 18 months into its $2.9 billion Backing Australia's Ability program, the Federal government is looking to adjust its innovation blueprint -- and that could involve culling some elements that aren't working, Science Minister Peter McGauran has foreshadowed.
Weak spots exposed by commercialisation survey
20 September, 2002 by Pete YoungA landmark survey of the commercialisation track record by Australia's publicly-funded research bodies shows worrying weak spots in a generally favourable picture.
US patent will soak up the red ink at Peptech: Kwik
20 September, 2002 by David BinningAustralian biotech hopeful Peptech got the green light from the US patents office for its Tumour Necrosis Factor Antibodies technique this week.
Product rollout keeps VRI confident despite loss
20 September, 2002 by Pete YoungNatural health products company VRI Biomedical has reason to be upbeat about its future despite posting the largest annual loss in its short history.
Tax offset to hurt small biotechs
20 September, 2002 by Graeme O'NeillThe Federal government's 'Backing Australia's Ability' package seems to have backed right over small biotechnology companies, crushing their hopes for substantial cash rebates on their R&D expenditure.
CAREERS SPECIAL: Digging for talent
17 September, 2002 by Pete YoungAustralia's growing biotech industry has sparked recruitment sector interest. Pete Young surveys the scene
CAREER SPECIAL: Risk and reward
17 September, 2002 by Graeme O'NeillGraeme O'Neill reports on the hiring challenges faced by small-to-medium Australian biotechs
Nanotech expert to assist Chief Scientist
16 September, 2002 by Graeme O'NeillCSIRO nanotechnology expert Dr Vijoleta Braach-Maksvytis has been appointed to a new, part-time role as head of the Office of the Chief Scientist, to assist Chief Scientist Dr Robin Batterham.
Agencies freed from external funding obligations
16 September, 2002 by Pete YoungAustralia's premier science research agencies have been freed of the mandatory need to earn up to 30 percent of their government-supplied income from external sources.
McGauran hopes R&D Start scheme will return in 2003
12 September, 2002 by Melissa TrudingerThe return of the Federal government's R&D Start grant scheme may be on the horizon, according to Federal Minister for Science Peter McGauran.
Proctor & Gamble to trial Ambri's biosensor
11 September, 2002 by Melissa TrudingerSydney-based company Ambri has announced that it has entered into an agreement with US consumer products giant Proctor & Gamble.
Analytica rises from the ashes
10 September, 2002 by Pete YoungThe Lazarus-like revival of diagnostics company Analytica offers a ray of hope for young Australian biotechs caught in the current funding drought.
The other Big Australian
09 September, 2002 by Melissa TrudingerAs Australia's biggest public research institution, CSIRO occupies a unique niche. Employing 6500 people, the organisation has a huge diversity of scientific skills to apply to Australia's industries.
Synchrotron seeking commercial director
06 September, 2002 by Melissa TrudingerThe Australian Synchrotron Project has progressed to the stage where it requires a commercial director to develop commercial and policy frameworks.
